Clinical Trials
10 trialsNCT06561360 2026-05-26
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT00412594 2025-12-22
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT01137643 2025-10-27
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
UNC Lineberger Comprehensive Cancer Center
Recruiting
NCT06340737 2025-08-07
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Stanford University
Phase 1 Recruiting
NCT00935090 2025-07-08
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Barbara Ann Karmanos Cancer Institute
Recruiting
NCT01137825 2025-06-25
Registry of Older Patients With Cancer
UNC Lineberger Comprehensive Cancer Center
Recruiting
NCT06781515 2025-01-17
BRAF
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase NA Recruiting
NCT06774677 2025-01-14
Decoding the Extracellular Vesicles-driven Communication in the Microenvironment of Hairy Cell Leukemia to Improve Patient Care Management
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
NCT06764524 2025-01-08
Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
NCT02131753 2024-08-22
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
University of Giessen
Phase 2/3 Recruiting